Sarah K Tasian, MD
University of Pennsylvania
H-index: 37
North America-United States
Top articles of Sarah K Tasian, MD
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
The Holy Grail of Second Complete Remission in Relapsed Pediatric T-acute Lymphoblastic Leukemia | The Hematologist | Sarah K Tasian | 2024/1/1 |
Correction: Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL | Leukemia | Ze Tian Chunhua Shi Guojun Yang Jason K Allen Qing Shi | 2024 |
Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: The role of kinase type and SH3 domain | Blood Journal | Inge van Outersterp Sarah K Tasian Caitlin EJ Reichert Aurélie Boeree Hester A de Groot-Kruseman | 2024/2/23 |
Success of Centralized Manufacturing of CD33 CAR T-Cells (CD33CART) for Children and Young Adults with Relapsed/Refractory AML | Transplantation and Cellular Therapy | Brian Bowser Xiaoyi Yang John Roach Julie Blake Kate Donnelly | 2024/2/1 |
Allosteric SHP2 inhibition increases apoptotic dependency on BCL2 and synergizes with venetoclax in FLT3-and KIT-mutant AML | Cell Reports Medicine | Bogdan Popescu Carlos Stahlhut Theodore C Tarver Sydney Wishner Bianca J Lee | 2023/11/21 |
Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies | Shefali Mehra Justin Taylor | 2024/1/28 | |
ATM Germline Pathogenic Variants Affect Treatment Outcomes in Children with Acute Lymphoblastic Leukemia/Lymphoma and Ataxia Telangiectasia | Blood | Sarah Elitzur Ruth Shiloh Jan Loeffen Agata Pastorczak Masatoshi Takagi | 2023/11/28 |
Intrinsic suppression of type I interferon production underlies the therapeutic efficacy of il-15-producing natural killer cells in B-cell acute lymphoblastic leukemia | Journal for Immunotherapy of Cancer | Anil Kumar Adeleh Taghi Khani Caroline Duault Soraya Aramburo Ashly Sanchez Ortiz | 2023 |
In Which Trial Do I Belong? The PedAL APAL2020SC and EuPAL 2021 Registry Sorting Hats for Relapsed/Refractory Pediatric Acute Leukemias | The Hematologist | Andrew D Hughes Sarah K Tasian | 2023/5/1 |
The Brilliant Success of Blinatumomab for Babies With Acute Lymphoblastic Leukemia | The Hematologist | Haley Newman Sarah K Tasian | 2023/11/1 |
Relapsed pediatric acute myeloid leukaemia: State-of-the-art in 2023 | Grace Egan Sarah K Tasian | 2023/9/9 | |
Human plasma cells engineered to secrete bispecifics drive effective in vivo leukemia killing | bioRxiv | Tyler F Hill Parnal Narvekar Gregory Asher Nathan Camp Kerri R Thomas | 2023/8/26 |
Alternative splicing of its 5′-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapies | Blood | Zhiwei Ang Luca Paruzzo Katharina E Hayer Carolin Schmidt Manuel Torres Diz | 2023/11/16 |
APAL2020SC Pediatric Acute Leukemia (PedAL) Screening Trial-Developing New Therapies for Relapsed Leukemias | Blood | Michele S Redell Todd A Alonzo Robert Gerbing Jim Wang Maureen M O'Brien | 2023/11/28 |
Understanding the Ontogeny of Our Tiniest Patients With Leukemia | The Hematologist | Sarah K Tasian | 2023/1/1 |
Down syndrome and leukemia: from basic mechanisms to clinical advances | André Baruchel Jean-Pierre Bourquin John Crispino Sergi Cuartero Henrik Hasle | 2023/10/10 | |
Clonal evolution mediates Menin-inhibitor resistance in KMT2A-rearranged leukemias | bioRxiv | Leila Mahdavi Alexandra Lenard Hongbo M Xie Simone S Riedel Fatemeh Alikarami | 2023/3/16 |
Taking the Pulse of ALL Maintenance Therapy | The Hematologist | Sarah K Tasian | 2023/9/1 |
CD38 as a pan-hematologic target for chimeric antigen receptor T cells | Blood Advances | Tina Glisovic-Aplenc Caroline Diorio John A Chukinas Kimberly Veliz Olga Shestova | 2023/8/22 |
Integration of Genomic Sequencing Drives Therapeutic Targeting of PDGFRA in T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma | Clinical Cancer Research | Jonathan Paolino Boris Dimitrov Beth Apsel Winger Angelica Sandoval-Perez Amith Vikram Rangarajan | 2023/11/14 |
Co-Authors
